[1]
2012. Low Leukocyte MGMT Accompanies Temozolomide-Induced Myelotoxicity in Brain Tumor Patients . Journal of Cancer Research Updates. 1, 1 (Jan. 2012),  44–48. DOI:https://doi.org/10.6000/1929-2279.2012.01.01.08.